miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer
Open Access
- 27 October 2017
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 16 (1) , 1-13
Abstract
MicroRNAs (miRNAs) can act as oncogenes or tumor suppressors by controlling cell proliferation, differentiation, metastasis and apoptosis, and miRNA dysregulation is involved in the development of pancreatic cancer (PC). Our previous study demonstrated that Gabra3 plays critical roles in cancer progression. However, whether Gabra3 is regulated by miRNAs in PC remains unknown. The expression levels of miR-92b-3p and Gabra3 were measured by quantitative PCR (qPCR), immunoblotting, in situ hybridization (ISH) and immunohistochemistry (IHC). The proliferation rate of PC cells was detected by MTS assay. Wound-healing and transwell assays were used to examine the invasive abilities of PC cells. Dual-luciferase reporter assays were used to determine how miR-92b-3p regulates Gabra3. Xenograft mouse models were used to assess the role of miR-92b-3p in PC tumor formation in vivo. Here, we provide evidence that miR-92b-3p acted as a tumor suppressor in PC by regulating Gabra3 expression. MiR-92b-3p expression levels were lower in PC tissues than corresponding noncancerous pancreatic (CNP) tissues and were associated with a poor prognosis in PC patients. MiR-92b-3p overexpression suppressed the proliferation and invasion of PC cells in both in vivo and in vitro models. Conversely, miR-92b-3p knockdown induced an aggressive phenotype in PC cells. Mechanistically, miR-92b-3p overexpression suppressed Gabra3 expression, which then led to the inactivation of important oncogenic pathways, including the AKT/mTOR and JNK pathways. Our results suggest that miR-92b-3p acted as a tumor suppressor by targeting Gabra3-associated oncogenic pathways; these results provide novel insight into future treatments for PC patients.Keywords
This publication has 37 references indexed in Scilit:
- Human breast cancer metastases to the brain display GABAergic properties in the neural nicheProceedings of the National Academy of Sciences, 2014
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic CancerJAMA, 2013
- Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activationMolecular Cancer, 2012
- miR-34 – a microRNA replacement therapy is headed to the clinicFrontiers in Genetics, 2012
- The Dynamic Modulation of GABAAReceptor Trafficking and Its Role in Regulating the Plasticity of Inhibitory SynapsesPhysiological Reviews, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem CellsStem Cells, 2009
- MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic PancreatitisJAMA, 2007
- A new role for GABA: inhibition of tumor cell migrationTrends in Pharmacological Sciences, 2003
- Pancreatic CarcinomaNew England Journal of Medicine, 1992